Literature DB >> 18437896

Autophagy and tumor suppression: recent advances in understanding the link between autophagic cell death pathways and tumor development.

Shani Bialik1, Adi Kimchi.   

Abstract

Autophagy is a process by which the cell recycles its components through self-consumption of cellular organelles and bulk cytoplasm. In times of stress, it serves to generate much needed nutrients. When overactivated, however, the orderly destruction of organelles can lead to cell death. At times, autophagic cell death is used as an alternative to apoptosis to eliminate unwanted, damaged, or transformed cells. Consistent with this, tumorigenesis is associated with a downregulation in autophagy, and genes that mediate the execution of the process have been shown to be tumor suppressors. At the same time, basal autophagy has been harnessed by some tumor cells as a survival mechanism to protect against ischemia and signals that induce apoptosis. Thus, the relationship between autophagy and tumor development is complex. Here, we discuss the basic machinery of mammalian autophagy and its regulators, with specific emphasis on those genes that have been linked to cancer. Research supporting the divergent nature of autophagy in both tumor suppression and tumor progression is presented. We conclude with a survey of recent approaches to treating cancer with strategies that modulate autophagy.

Entities:  

Mesh:

Year:  2008        PMID: 18437896     DOI: 10.1007/978-1-4020-6554-5_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  21 in total

1.  Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.

Authors:  Dong Liang; Larissa Meyer; David W Chang; Jie Lin; Xia Pu; Yuanqing Ye; Jian Gu; Xifeng Wu; Karen Lu
Journal:  Cancer Res       Date:  2010-11-30       Impact factor: 12.701

2.  Deleting key autophagy elongation proteins induces acquirement of tumor-associated phenotypes via ISG15.

Authors:  EunBin Kong; Hag Dong Kim; Joon Kim
Journal:  Cell Death Differ       Date:  2020-03-03       Impact factor: 15.828

3.  Rapamycin induces autophagy in the melanoma cell line M14 via regulation of the expression levels of Bcl-2 and Bax.

Authors:  Xue Li; DI Wu; Jinggang Shen; Meihua Zhou; Yan Lu
Journal:  Oncol Lett       Date:  2012-10-22       Impact factor: 2.967

4.  MicroRNA regulation of DNA repair gene expression in hypoxic stress.

Authors:  Meredith E Crosby; Ritu Kulshreshtha; Mircea Ivan; Peter M Glazer
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

5.  Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation.

Authors:  Chew Hooi Wong; Kartini Bte Iskandar; Sanjiv Kumar Yadav; Jayshree L Hirpara; Thomas Loh; Shazib Pervaiz
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

6.  Immunohistochemical expression of MAP1LC3A and MAP1LC3B protein in breast carcinoma tissues.

Authors:  Ekhlas Qaid Gazem Othman; Gurjeet Kaur; Ahmad Faisal Mutee; Tengku Sifzizul Tengku Muhammad; Mei Lan Tan
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 7.  Programmed cell death pathways and current antitumor targets.

Authors:  Mei Lan Tan; Jer Ping Ooi; Nawfal Ismail; Ahmed Ismail Hassan Moad; Tengku Sifzizul Tengku Muhammad
Journal:  Pharm Res       Date:  2009-04-30       Impact factor: 4.200

8.  NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitor erlotinib in head and neck cancer cells.

Authors:  Arya Sobhakumari; Brandon M Schickling; Laurie Love-Homan; Ayanna Raeburn; Elise V M Fletcher; Adam J Case; Frederick E Domann; Francis J Miller; Andrean L Simons
Journal:  Toxicol Appl Pharmacol       Date:  2013-07-31       Impact factor: 4.219

Review 9.  Molecular imaging metrics to evaluate response to preclinical therapeutic regimens.

Authors:  R Adam Smith; Saffet Guleryuz; H Charles Manning
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

10.  The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment.

Authors:  Dan-Dan Li; Ting Sun; Xiao-Qi Wu; Shu-Peng Chen; Rong Deng; Shan Jiang; Gong-Kan Feng; Jing-Xuan Pan; Xiao-Shi Zhang; Yi-Xin Zeng; Xiao-Feng Zhu
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.